170 related articles for article (PubMed ID: 26701982)
1. Utility of Prostate Cancer Screening in Kidney Transplant Candidates.
Vitiello GA; Sayed BA; Wardenburg M; Perez SD; Keith CG; Canter DJ; Ogan K; Pearson TC; Turgeon N
J Am Soc Nephrol; 2016 Jul; 27(7):2157-63. PubMed ID: 26701982
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer.
Aminsharifi A; Simon R; Polascik TJ; Robertson CN; Sudan DL; Collins BH; Moul JW
J Urol; 2019 Sep; 202(3):469-474. PubMed ID: 30835631
[TBL] [Abstract][Full Text] [Related]
3. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications.
Gershman B; Van Houten HK; Herrin J; Moreira DM; Kim SP; Shah ND; Karnes RJ
Eur Urol; 2017 Jan; 71(1):55-65. PubMed ID: 26995328
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen screening and prostate cancer treatment in renal transplantation candidates: A survey of U.S. transplantation centers.
Gin GE; Pereira JF; Weinberg AD; Mehrazin R; Lerner SM; Sfakianos JP; Phillips CK
Urol Oncol; 2016 Feb; 34(2):57.e9-13. PubMed ID: 26433443
[TBL] [Abstract][Full Text] [Related]
6. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
Hua LX; Qiao D; Song NH; Feng NH; Yang J; Zhang JX; Chen JG; Zhang W; Sui YG; Wu HF
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
[TBL] [Abstract][Full Text] [Related]
7. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
8. Contemporary National Trends of Prostate Cancer Screening Among Privately Insured Men in the United States.
Kim SP; Karnes RJ; Gross CP; Meropol NJ; Van Houten H; Abouassaly R; Shah ND
Urology; 2016 Nov; 97():111-117. PubMed ID: 27527411
[TBL] [Abstract][Full Text] [Related]
9. Effect of kidney transplantation on early and late post-transplant prostate-specific antigen levels.
Mahdavi R; Zeraati A; Tavakkoli M; Aghamohammadpour K; Ghoreifi A
Saudi J Kidney Dis Transpl; 2014 Mar; 25(2):362-6. PubMed ID: 24626004
[TBL] [Abstract][Full Text] [Related]
10. The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer.
Chamie K; Ghosh PM; Koppie TM; Romero V; Troppmann C; deVere White RW
Am J Transplant; 2008 Dec; 8(12):2668-73. PubMed ID: 18853950
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer screening and treatment in the transplant population: current status and recommendations.
Breyer BN; Whitson JM; Freise CE; Meng MV
J Urol; 2009 May; 181(5):2018-25; discussion 2025-6. PubMed ID: 19286214
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen values and their clinical significance in renal transplant recipients.
Ha R; Jindal RM; Milgrom MM; Leapman SB; Filo RS; Pescovitz MD
South Med J; 1998 Sep; 91(9):847-50. PubMed ID: 9743056
[TBL] [Abstract][Full Text] [Related]
13. [Urologic malignancies in renal transplant candidates and recipients].
Kleinclauss F; Thuret R; Murez T; Timsit MO
Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
[TBL] [Abstract][Full Text] [Related]
14. [Localized Prostate cancer in candidates for renal transplantation and recipients of a kidney transplant: The French Guidelines from CTAFU].
Culty T; Goujon A; Defortescu G; Bessede T; Kleinclauss F; Boissier R; Drouin S; Branchereau J; Doerfler A; Prudhomme T; Matillon X; Verhoest G; Tillou X; Ploussard G; Rozet F; Méjean A; Timsit MO
Prog Urol; 2021 Jan; 31(1):4-17. PubMed ID: 33423746
[TBL] [Abstract][Full Text] [Related]
15. Over-diagnosed prostate cancer in solid organ recipients: lessons from the last 3 decades.
Waeckel T; Ait Said K; Altieri M; Belin A; Doerfler A; Tillou X
Int Urol Nephrol; 2021 Feb; 53(2):241-248. PubMed ID: 32926314
[TBL] [Abstract][Full Text] [Related]
16. Mass screening for prostate cancer in patients with end-stage renal disease: a comparative study.
Wada Y; Nakanishi J; Takahashi W; Kai N; Nakayama Y; Yamashita Y; Honda J; Ueda S
BJU Int; 2006 Oct; 98(4):794-7. PubMed ID: 16978274
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
Hayat Roshanai A; Nordin K; Berglund G
Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
[TBL] [Abstract][Full Text] [Related]
18. Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.
Carlsson S; Assel M; Ulmert D; Gerdtsson A; Hugosson J; Vickers A; Lilja H
Eur Urol; 2017 Jan; 71(1):46-52. PubMed ID: 27084245
[TBL] [Abstract][Full Text] [Related]
19. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
20. Should all colorectal cancer patients over age 60 be screened for prostate cancer?
Aizer AA; D'Amico AV
Oncology (Williston Park); 2013 Oct; 27(10):1032-8. PubMed ID: 24367864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
